Concepts (145)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Off-Label Use | 2 | 2012 | 15 | 0.710 |
Why?
|
| Hypnotics and Sedatives | 3 | 2012 | 32 | 0.670 |
Why?
|
| Anesthesia | 4 | 2012 | 72 | 0.620 |
Why?
|
| Analgesics | 2 | 2012 | 117 | 0.400 |
Why?
|
| Pediatrics | 2 | 2012 | 167 | 0.400 |
Why?
|
| Drug Labeling | 1 | 2012 | 4 | 0.380 |
Why?
|
| Anesthetics | 1 | 2012 | 21 | 0.370 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 40 | 0.370 |
Why?
|
| Malignant Hyperthermia | 2 | 2008 | 6 | 0.350 |
Why?
|
| Drug Approval | 2 | 2010 | 13 | 0.330 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2009 | 222 | 0.320 |
Why?
|
| Estrogens | 2 | 2009 | 210 | 0.320 |
Why?
|
| Infant, Newborn | 2 | 2010 | 730 | 0.320 |
Why?
|
| Hospitalization | 1 | 2012 | 500 | 0.300 |
Why?
|
| Neuroprotective Agents | 1 | 2009 | 34 | 0.300 |
Why?
|
| Dexmedetomidine | 2 | 2006 | 12 | 0.290 |
Why?
|
| Conscious Sedation | 2 | 2006 | 26 | 0.290 |
Why?
|
| Disaster Planning | 1 | 2009 | 34 | 0.290 |
Why?
|
| Models, Animal | 1 | 2009 | 198 | 0.290 |
Why?
|
| Consensus | 1 | 2009 | 91 | 0.290 |
Why?
|
| Synapses | 1 | 2009 | 89 | 0.290 |
Why?
|
| Menopause | 1 | 2009 | 111 | 0.280 |
Why?
|
| Midazolam | 1 | 2008 | 11 | 0.270 |
Why?
|
| Critical Care | 1 | 2009 | 113 | 0.270 |
Why?
|
| Registries | 1 | 2008 | 328 | 0.250 |
Why?
|
| Child Advocacy | 1 | 2006 | 1 | 0.250 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2006 | 16 | 0.240 |
Why?
|
| Ethics, Research | 1 | 2006 | 25 | 0.240 |
Why?
|
| Brain | 3 | 2009 | 1031 | 0.230 |
Why?
|
| Publishing | 1 | 2006 | 66 | 0.230 |
Why?
|
| Cognition | 1 | 2009 | 576 | 0.230 |
Why?
|
| Pyloric Stenosis | 1 | 2004 | 4 | 0.210 |
Why?
|
| Hyperkalemia | 1 | 2004 | 16 | 0.210 |
Why?
|
| Anemia, Sickle Cell | 1 | 2004 | 45 | 0.200 |
Why?
|
| Perioperative Care | 1 | 2004 | 57 | 0.200 |
Why?
|
| Humans | 13 | 2012 | 34474 | 0.150 |
Why?
|
| Child | 5 | 2009 | 2613 | 0.150 |
Why?
|
| Age Factors | 3 | 2009 | 1261 | 0.130 |
Why?
|
| Animals | 9 | 2009 | 8544 | 0.100 |
Why?
|
| Neurons | 2 | 2009 | 491 | 0.090 |
Why?
|
| Pain, Postoperative | 2 | 2004 | 205 | 0.090 |
Why?
|
| Vesicular Acetylcholine Transport Proteins | 2 | 2009 | 4 | 0.090 |
Why?
|
| Female | 7 | 2012 | 21490 | 0.090 |
Why?
|
| Pain Threshold | 3 | 2005 | 105 | 0.080 |
Why?
|
| Nitric Oxide | 1 | 2010 | 124 | 0.080 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2009 | 6 | 0.080 |
Why?
|
| Macaca fascicularis | 2 | 2009 | 548 | 0.080 |
Why?
|
| Health Resources | 1 | 2009 | 35 | 0.070 |
Why?
|
| Delphi Technique | 1 | 2009 | 44 | 0.070 |
Why?
|
| North America | 1 | 2008 | 34 | 0.070 |
Why?
|
| Anesthetics, Inhalation | 1 | 2008 | 20 | 0.070 |
Why?
|
| Basal Nucleus of Meynert | 2 | 2009 | 5 | 0.070 |
Why?
|
| Clinical Trials as Topic | 1 | 2010 | 325 | 0.070 |
Why?
|
| Estrogens, Conjugated (USP) | 1 | 2009 | 159 | 0.070 |
Why?
|
| Male | 7 | 2012 | 20697 | 0.070 |
Why?
|
| Aging | 2 | 2004 | 1010 | 0.060 |
Why?
|
| Child, Preschool | 2 | 2009 | 1354 | 0.060 |
Why?
|
| Spinal Nerves | 2 | 2005 | 72 | 0.060 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 2005 | 46 | 0.060 |
Why?
|
| United States Food and Drug Administration | 1 | 2006 | 53 | 0.060 |
Why?
|
| Informed Consent | 1 | 2006 | 45 | 0.060 |
Why?
|
| Open Reading Frames | 1 | 2005 | 21 | 0.060 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 1 | 2005 | 21 | 0.060 |
Why?
|
| GTP-Binding Proteins | 1 | 2005 | 40 | 0.060 |
Why?
|
| Receptors, Adrenergic, alpha-2 | 1 | 2005 | 35 | 0.060 |
Why?
|
| Sciatic Nerve | 1 | 2004 | 39 | 0.050 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2004 | 1 | 0.050 |
Why?
|
| Tourniquets | 1 | 2004 | 12 | 0.050 |
Why?
|
| Vesicular Transport Proteins | 1 | 2004 | 12 | 0.050 |
Why?
|
| Blood Volume | 1 | 2004 | 9 | 0.050 |
Why?
|
| Cholinergic Fibers | 1 | 2004 | 10 | 0.050 |
Why?
|
| Parietal Lobe | 1 | 2004 | 17 | 0.050 |
Why?
|
| Cavernous Sinus Thrombosis | 1 | 2004 | 2 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2005 | 150 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 41 | 0.050 |
Why?
|
| Sinusitis | 1 | 2004 | 16 | 0.050 |
Why?
|
| Nerve Block | 1 | 2004 | 63 | 0.050 |
Why?
|
| Infant | 2 | 2004 | 1122 | 0.050 |
Why?
|
| Prefrontal Cortex | 1 | 2004 | 90 | 0.050 |
Why?
|
| Hyperalgesia | 1 | 2003 | 86 | 0.050 |
Why?
|
| Unconsciousness | 1 | 2002 | 5 | 0.050 |
Why?
|
| Anesthetics, Combined | 1 | 2002 | 6 | 0.050 |
Why?
|
| Anesthetics, Intravenous | 1 | 2002 | 20 | 0.050 |
Why?
|
| Mutation | 1 | 2005 | 529 | 0.050 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2004 | 108 | 0.050 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2002 | 11 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 1 | 2002 | 104 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2005 | 849 | 0.040 |
Why?
|
| Adenosine | 1 | 2002 | 74 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 4 | 2005 | 923 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2005 | 765 | 0.040 |
Why?
|
| Pain | 1 | 2002 | 330 | 0.040 |
Why?
|
| Rats | 4 | 2005 | 1946 | 0.040 |
Why?
|
| Adult | 2 | 2008 | 10015 | 0.030 |
Why?
|
| United States | 1 | 2006 | 4267 | 0.030 |
Why?
|
| Cell Count | 2 | 2009 | 55 | 0.030 |
Why?
|
| Ovariectomy | 2 | 2009 | 204 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2009 | 508 | 0.030 |
Why?
|
| Aged | 1 | 2008 | 10998 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 593 | 0.030 |
Why?
|
| Ligation | 2 | 2005 | 65 | 0.030 |
Why?
|
| Diagonal Band of Broca | 1 | 2009 | 2 | 0.020 |
Why?
|
| Septal Nuclei | 1 | 2009 | 16 | 0.020 |
Why?
|
| Cell Size | 1 | 2009 | 43 | 0.020 |
Why?
|
| Estradiol | 1 | 2009 | 156 | 0.020 |
Why?
|
| Yohimbine | 1 | 2005 | 7 | 0.010 |
Why?
|
| Guanosine Triphosphate | 1 | 2005 | 12 | 0.010 |
Why?
|
| Mechanoreceptors | 1 | 2005 | 43 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2005 | 54 | 0.010 |
Why?
|
| Random Allocation | 1 | 2005 | 257 | 0.010 |
Why?
|
| Hindlimb | 1 | 2004 | 55 | 0.010 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2004 | 6 | 0.010 |
Why?
|
| Time | 1 | 2004 | 29 | 0.010 |
Why?
|
| Viridans Streptococci | 1 | 2004 | 5 | 0.010 |
Why?
|
| Blindness | 1 | 2004 | 13 | 0.010 |
Why?
|
| Bupivacaine | 1 | 2004 | 60 | 0.010 |
Why?
|
| Streptococcal Infections | 1 | 2004 | 23 | 0.010 |
Why?
|
| Acetylcholine | 1 | 2004 | 69 | 0.010 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2004 | 31 | 0.010 |
Why?
|
| Respiratory Distress Syndrome, Adult | 1 | 2004 | 51 | 0.010 |
Why?
|
| Anesthetics, Local | 1 | 2004 | 96 | 0.010 |
Why?
|
| Physical Stimulation | 1 | 2003 | 89 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2003 | 89 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2004 | 149 | 0.010 |
Why?
|
| Anesthesia Recovery Period | 1 | 2002 | 4 | 0.010 |
Why?
|
| Methohexital | 1 | 2002 | 7 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2002 | 29 | 0.010 |
Why?
|
| Cardiac Output | 1 | 2002 | 37 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 276 | 0.010 |
Why?
|
| Propofol | 1 | 2002 | 22 | 0.010 |
Why?
|
| Fentanyl | 1 | 2002 | 37 | 0.010 |
Why?
|
| Xanthines | 1 | 2002 | 10 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2002 | 26 | 0.010 |
Why?
|
| Microdialysis | 1 | 2002 | 41 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2003 | 385 | 0.010 |
Why?
|
| Oxygen | 1 | 2002 | 152 | 0.010 |
Why?
|
| Injections, Spinal | 1 | 2002 | 124 | 0.010 |
Why?
|
| Piperidines | 1 | 2002 | 141 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2003 | 303 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 352 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 1118 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 755 | 0.010 |
Why?
|
| Heart Rate | 1 | 2002 | 372 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2002 | 2461 | 0.010 |
Why?
|
| Middle Aged | 1 | 2002 | 12703 | 0.000 |
Why?
|